320 related articles for article (PubMed ID: 2431626)
1. Structural features of various proglumide-related cholecystokinin receptor antagonists.
Jensen RT; Zhou ZC; Murphy RB; Jones SW; Setnikar I; Rovati LA; Gardner JD
Am J Physiol; 1986 Dec; 251(6 Pt 1):G839-46. PubMed ID: 2431626
[TBL] [Abstract][Full Text] [Related]
2. Proglumide analogues: potent cholecystokinin receptor antagonists.
Jensen RT; Murphy RB; Trampota M; Schneider LH; Jones SW; Howard JM; Gardner JD
Am J Physiol; 1985 Aug; 249(2 Pt 1):G214-20. PubMed ID: 2411147
[TBL] [Abstract][Full Text] [Related]
3. New proglumide-analogue CCK receptor antagonists: very potent and selective for peripheral tissues.
Niederau C; Niederau M; Williams JA; Grendell JH
Am J Physiol; 1986 Jun; 250(6 Pt 1):G856-60. PubMed ID: 2424321
[TBL] [Abstract][Full Text] [Related]
4. CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini.
Iwamoto Y; Yamamoto R; Kuzuya T
Pancreas; 1987; 2(1):85-90. PubMed ID: 2437574
[TBL] [Abstract][Full Text] [Related]
5. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic receptors for cholecystokinin: evidence for three receptor classes.
Yu DH; Huang SC; Wank SA; Mantey S; Gardner JD; Jensen RT
Am J Physiol; 1990 Jan; 258(1 Pt 1):G86-95. PubMed ID: 2301586
[TBL] [Abstract][Full Text] [Related]
7. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
Menozzi D; Gardner JD; Jensen RT; Maton PN
Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
[TBL] [Abstract][Full Text] [Related]
8. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
[TBL] [Abstract][Full Text] [Related]
9. [Inhibitory effect of a new proglumide derivative, loxiglumide, on CCK action in isolated rat pancreatic acini].
Fujii M; Otsuki M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):77-82. PubMed ID: 2471851
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.
Makovec F; Bani M; Cereda R; Chisté R; Pacini MA; Revel L; Rovati LA; Rovati LC; Setnikar I
Arzneimittelforschung; 1987 Nov; 37(11):1265-8. PubMed ID: 3440035
[TBL] [Abstract][Full Text] [Related]
11. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
Gardner JD; Knight M; Sutliff VE; Jensen RT
Am J Physiol; 1985 Jan; 248(1 Pt 1):G98-102. PubMed ID: 2578257
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin receptors on gallbladder muscle and pancreatic acinar cells: a comparative study.
von Schrenck T; Moran TH; Heinz-Erian P; Gardner JD; Jensen RT
Am J Physiol; 1988 Oct; 255(4 Pt 1):G512-21. PubMed ID: 3177648
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
Louie DS; Liang JP; Owyang C
Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
[TBL] [Abstract][Full Text] [Related]
14. Effects of proglumide on pancreatic acinar cell function.
Williams JA; Bailey A; Steigerwalt RW
Digestion; 1983; 27(4):227-33. PubMed ID: 6197332
[TBL] [Abstract][Full Text] [Related]
15. Asperlicin: a unique nonpeptide cholecystokinin antagonist.
Zucker KA; Adrian TE; Zdon MJ; Ballantyne GH; Modlin IM
Surgery; 1987 Aug; 102(2):163-70. PubMed ID: 2441481
[TBL] [Abstract][Full Text] [Related]
16. Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists.
Hahne WF; Jensen RT; Lemp GF; Gardner JD
Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6304-8. PubMed ID: 6171817
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of FK480, a novel cholecystokinin type-A receptor antagonist: comparison to loxiglumide.
Ito H; Sogabe H; Nakarai T; Sato Y; Tomoi M; Kadowaki M; Matsuo M; Tokoro K; Yoshida K
J Pharmacol Exp Ther; 1994 Feb; 268(2):571-5. PubMed ID: 7509389
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonist.
Setnikar I; Bani M; Cereda R; Chisté R; Makovec F; Pacini MA; Revel L; Rovati LC; Rovati LA
Arzneimittelforschung; 1987 Jun; 37(6):703-7. PubMed ID: 3663268
[TBL] [Abstract][Full Text] [Related]
19. Receptor type for cholecystokinin on isolated intestinal muscle cells of the guinea pig.
Morini G; Barocelli E; Impicciatore M; Grider JR; Makhlouf GM
Regul Pept; 1990 May; 28(3):313-21. PubMed ID: 2377745
[TBL] [Abstract][Full Text] [Related]
20. Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
Gardner JD; Knight M; Sutliff VE; Tamminga CA; Jensen RT
Am J Physiol; 1984 Mar; 246(3 Pt 1):G292-5. PubMed ID: 6199984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
